Phreesia Inc
NYSE:PHR
Phreesia Inc
NYSE:PHR
Price:
21.95 USD
0.05%
Market Closed
Updated:
May 9, 2024
Phreesia Inc
Income from Continuing Operations
|
Phreesia Inc
Income from Continuing Operations Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
GDRX
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Phreesia Inc
NYSE:PHR
|
Income from Continuing Operations
-$136.9m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Income from Continuing Operations
$525.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
36%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Income from Continuing Operations
-$21.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Income from Continuing Operations
-$113m
|
CAGR 3-Years
30%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Income from Continuing Operations
$112.8m
|
CAGR 3-Years
56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Income from Continuing Operations
-$8.9m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Phreesia Inc's Income from Continuing Operations?
Income from Continuing Operations
-136.9m
USD
-136.9m
USD
Based on the financial report for Jan 31, 2024, Phreesia Inc's Income from Continuing Operations amounts to -136.9m USD.
What is Phreesia Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-55%
-55%
Over the last year, the Income from Continuing Operations growth was 22%. The average annual Income from Continuing Operations growth rates for Phreesia Inc have been -71% over the past three years , -55% over the past five years .
You don't have any saved screeners yet
